Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04707911 · ClinicalTrials.gov registry record · NA

Social Media Intervention to Stop Nicotine and Cannabis Vaping Among Adolescents

A NA study of Vaping, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT04707911: Completed NA study of Vaping, sponsored by University of California, San Francisco.

NCT04707911 is a NA study of Vaping that has completed, run by University of California, San Francisco. The registered enrollment target is 500 participants, below the 733-participant average among 18 other Vaping trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04707911, a NA study of Vaping, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

Social media based intervention to support teens in their efforts to quit vaping.

Primary Outcome

7-day point prevalence abstinence (PPA) from all tobacco products will be assessed over the course of the study. Participants reporting no vaping in the past 7 days will be coded as abstinent. Those reporting 7-day abstinence and not using nicotine replacement therapy will be mailed saliva cotinine test kit and saliva tetrahydrocannabinol (THC) test kit for biochemical verification of abstinence.

Conditions Studied

Interventions

  • BEHAVIORAL Social Media Intervention

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2021-11-18
Est. Completion 2024-06-18
Phase NA

What the finished NCT04707911 record still lists

NCT04707911 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 733-participant average among 18 other Vaping trials with a reported enrollment target (32% lower).

The record links to 1 condition, with Vaping appearing as the primary indexed condition, and to 1 intervention - of which Social Media Intervention is the first listed.

NCT04707911 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04707911 about?

NCT04707911 is a clinical study titled "Social Media Intervention to Stop Nicotine and Cannabis Vaping Among Adolescents". Social media based intervention to support teens in their efforts to quit vaping.

What is the current status of trial NCT04707911?

This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2021-11-18. Estimated completion is 2024-06-18.

What conditions does trial NCT04707911 study?

This clinical trial studies the following conditions: Vaping.

What interventions are being tested in trial NCT04707911?

The interventions under investigation include: Social Media Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04707911?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04707911 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vaping

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04707911's enrollment target sits among peer trials

500 6th of 18 higher than 12 of 18 other Vaping trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Vaping trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04707911, the US trial registry maintained by the National Library of Medicine. NCT04707911 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.